Skip to main content
Erschienen in: Diabetologia 4/2018

24.12.2017 | Article

Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort

verfasst von: Luke W. Johnston, Stewart B. Harris, Ravi Retnakaran, Adria Giacca, Zhen Liu, Richard P. Bazinet, Anthony J. Hanley

Erschienen in: Diabetologia | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Our aim was to determine the longitudinal associations of individual NEFA with the pathogenesis of diabetes, specifically with differences in insulin sensitivity and beta cell function over 6 years in a cohort of individuals who are at risk for diabetes.

Methods

In the Prospective Metabolism and Islet Cell Evaluation (PROMISE) longitudinal cohort, 477 participants had serum NEFA measured at the baseline visit and completed an OGTT at three time points over 6 years. Outcome variables were calculated using the OGTT values. At each visit, insulin sensitivity was assessed using the HOMA2 of insulin sensitivity (HOMA2-%S) and the Matsuda index, while beta cell function was assessed using the insulinogenic index over HOMA-IR (IGI/IR) and the insulin secretion-sensitivity index-2 (ISSI-2). Generalised estimating equations were used, adjusting for time, waist, sex, ethnicity, baseline age, alanine aminotransferase (ALT) and physical activity. NEFA were analysed as both concentrations (nmol/ml) and proportions (mol%) of the total fraction.

Results

Participants’ (73% female, 70% with European ancestry) insulin sensitivity and beta cell function declined by 14–21% over 6 years of follow-up. In unadjusted models, several NEFA (e.g. 18:1 n-7, 22:4 n-6) were associated with lower insulin sensitivity, however, nearly all of these associations were attenuated in fully adjusted models. In adjusted models, total NEFA, 16:0, 18:1 n-9 and 18:2 n-6 (as concentrations) were associated with 3.7–8.0% lower IGI/IR and ISSI-2, while only 20:5 n-3 (as mol%) was associated with 7.7% higher HOMA2-%S.

Conclusions/interpretation

Total NEFA concentration was a strong predictor of lower beta cell function over 6 years. Our results suggest that the association with beta cell function is due to the absolute size of the serum NEFA fraction, rather than the specific fatty acid composition.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rachek LI (2014) Free fatty acids and skeletal muscle insulin resistance. Prog Mol Biol Transl Sci 121:267–292CrossRefPubMed Rachek LI (2014) Free fatty acids and skeletal muscle insulin resistance. Prog Mol Biol Transl Sci 121:267–292CrossRefPubMed
2.
Zurück zum Zitat Cnop M (2008) Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. Biochem Soc Trans 36:348–352CrossRefPubMed Cnop M (2008) Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. Biochem Soc Trans 36:348–352CrossRefPubMed
3.
Zurück zum Zitat Paolisso G, Tataranni PA, Foley JE et al (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213–1217CrossRefPubMed Paolisso G, Tataranni PA, Foley JE et al (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213–1217CrossRefPubMed
4.
Zurück zum Zitat Salgin B, Ong KK, Thankamony A et al (2012) Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes. J Clin Endocrinol Metab 97:3302–3309CrossRefPubMed Salgin B, Ong KK, Thankamony A et al (2012) Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes. J Clin Endocrinol Metab 97:3302–3309CrossRefPubMed
5.
Zurück zum Zitat Kato T, Shimano H, Yamamoto T et al (2008) Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Diabetes 57:2382–2392CrossRefPubMedPubMedCentral Kato T, Shimano H, Yamamoto T et al (2008) Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Diabetes 57:2382–2392CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Maris M, Robert S, Waelkens E et al (2013) Role of the saturated nonesterified fatty acid palmitate in beta cell dysfunction. J Proteome Res 12:347–362CrossRefPubMed Maris M, Robert S, Waelkens E et al (2013) Role of the saturated nonesterified fatty acid palmitate in beta cell dysfunction. J Proteome Res 12:347–362CrossRefPubMed
7.
Zurück zum Zitat Deguil J, Pineau L, Rowland Snyder EC et al (2011) Modulation of lipid-induced ER stress by fatty acid shape. Traffic 12:349–362CrossRefPubMed Deguil J, Pineau L, Rowland Snyder EC et al (2011) Modulation of lipid-induced ER stress by fatty acid shape. Traffic 12:349–362CrossRefPubMed
8.
Zurück zum Zitat Szendroedi J, Frossard M, Klein N et al (2012) Lipid-induced insulin resistance is not mediated by impaired transcapillary transport of insulin and glucose in humans. Diabetes 61:3176–3180CrossRefPubMedPubMedCentral Szendroedi J, Frossard M, Klein N et al (2012) Lipid-induced insulin resistance is not mediated by impaired transcapillary transport of insulin and glucose in humans. Diabetes 61:3176–3180CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Daniele G, Eldor R, Merovci A et al (2014) Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals. Diabetes 63:2812–2820CrossRefPubMedPubMedCentral Daniele G, Eldor R, Merovci A et al (2014) Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals. Diabetes 63:2812–2820CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Liang H, Tantiwong P, Sriwijitkamol A et al (2013) Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects. J Physiol 591:2897–2909CrossRefPubMedPubMedCentral Liang H, Tantiwong P, Sriwijitkamol A et al (2013) Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects. J Physiol 591:2897–2909CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Kehlenbrink S, Koppaka S, Martin M et al (2012) Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis. Diabetologia 55:3021–3028CrossRefPubMed Kehlenbrink S, Koppaka S, Martin M et al (2012) Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis. Diabetologia 55:3021–3028CrossRefPubMed
12.
Zurück zum Zitat Miller MR, Pereira RI, Langefeld CD et al (2012) Levels of free fatty acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in Hispanic Americans: The IRAS Family Study. J Clin Endocrinol Metab 97:3285–3291CrossRefPubMedPubMedCentral Miller MR, Pereira RI, Langefeld CD et al (2012) Levels of free fatty acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in Hispanic Americans: The IRAS Family Study. J Clin Endocrinol Metab 97:3285–3291CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Johns I, Goff L, Bluck LJ et al (2014) Plasma free fatty acids do not provide the link between obesity and insulin resistance or beta-cell dysfunction: Results of the Reading, Imperial, Surrey, Cambridge, Kings (RISCK) study. Diabet Med 31:1310–1315CrossRefPubMed Johns I, Goff L, Bluck LJ et al (2014) Plasma free fatty acids do not provide the link between obesity and insulin resistance or beta-cell dysfunction: Results of the Reading, Imperial, Surrey, Cambridge, Kings (RISCK) study. Diabet Med 31:1310–1315CrossRefPubMed
14.
Zurück zum Zitat Charles MA, Eschwège E, Thibult N et al (1997) The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: Results of the Paris prospective study. Diabetologia 40:1101–1106CrossRefPubMed Charles MA, Eschwège E, Thibult N et al (1997) The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: Results of the Paris prospective study. Diabetologia 40:1101–1106CrossRefPubMed
16.
Zurück zum Zitat Matthan NR, Ip B, Resteghini N et al (2010) Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions. J Lipid Res 51:2826–2832CrossRefPubMedPubMedCentral Matthan NR, Ip B, Resteghini N et al (2010) Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions. J Lipid Res 51:2826–2832CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509PubMed Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509PubMed
18.
Zurück zum Zitat Nishi S, Kendall CWC, Gascoyne A-M et al (2014) Effect of almond consumption on the serum fatty acid profile: a dose-response study. Br J Nutr 112:1137–1146CrossRefPubMedPubMedCentral Nishi S, Kendall CWC, Gascoyne A-M et al (2014) Effect of almond consumption on the serum fatty acid profile: a dose-response study. Br J Nutr 112:1137–1146CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Johnston LW, Harris SB, Retnakaran R et al (2016) Longitudinal associations of phospholipid and cholesteryl ester fatty acids with disorders underlying diabetes. J Clin Endocrinol Metab 101:2536–2544CrossRefPubMed Johnston LW, Harris SB, Retnakaran R et al (2016) Longitudinal associations of phospholipid and cholesteryl ester fatty acids with disorders underlying diabetes. J Clin Endocrinol Metab 101:2536–2544CrossRefPubMed
20.
Zurück zum Zitat Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191–2192CrossRefPubMed Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191–2192CrossRefPubMed
21.
Zurück zum Zitat Matsuda M, DeFronzo R (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed Matsuda M, DeFronzo R (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed
22.
Zurück zum Zitat Abdul-Ghani M, Matsuda M, Balas B, DeFronzo R (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94CrossRefPubMed Abdul-Ghani M, Matsuda M, Balas B, DeFronzo R (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94CrossRefPubMed
23.
Zurück zum Zitat Wareham N, Phillips D, Byrne C, Hales C (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12:931CrossRefPubMed Wareham N, Phillips D, Byrne C, Hales C (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12:931CrossRefPubMed
24.
Zurück zum Zitat Retnakaran R, Qi Y, Goran M, Hamilton J (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26:1198–1203CrossRefPubMed Retnakaran R, Qi Y, Goran M, Hamilton J (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26:1198–1203CrossRefPubMed
25.
Zurück zum Zitat Hermans MP, Levy JC, Morris RJ, Turner RC (1999) Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42:678–687CrossRefPubMed Hermans MP, Levy JC, Morris RJ, Turner RC (1999) Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42:678–687CrossRefPubMed
26.
Zurück zum Zitat Kriska A, Knowler W, LaPorte R et al (1990) Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13:401–411CrossRefPubMed Kriska A, Knowler W, LaPorte R et al (1990) Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13:401–411CrossRefPubMed
27.
Zurück zum Zitat Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121–130CrossRefPubMed Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121–130CrossRefPubMed
28.
Zurück zum Zitat Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10:37–48CrossRefPubMed Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10:37–48CrossRefPubMed
29.
Zurück zum Zitat Textor J, Hardt J, Knüppel S (2011) DAGitty: A graphical tool for analyzing causal diagrams. Epidemiology 22:745CrossRefPubMed Textor J, Hardt J, Knüppel S (2011) DAGitty: A graphical tool for analyzing causal diagrams. Epidemiology 22:745CrossRefPubMed
31.
Zurück zum Zitat Pan W (2001) Akaike’s information criterion in generalized estimating equations. Biometrics 57:120–125CrossRefPubMed Pan W (2001) Akaike’s information criterion in generalized estimating equations. Biometrics 57:120–125CrossRefPubMed
32.
Zurück zum Zitat Barrows BR, Parks EJ (2006) Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab 91:1446–1452CrossRefPubMed Barrows BR, Parks EJ (2006) Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab 91:1446–1452CrossRefPubMed
33.
Zurück zum Zitat R Core Team (2015) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna R Core Team (2015) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna
34.
Zurück zum Zitat Højsgaard S, Halekoh U, Yan J (2006) The R package geepack for generalized estimating equations. J Stat Softw 15(2):1–11 Højsgaard S, Halekoh U, Yan J (2006) The R package geepack for generalized estimating equations. J Stat Softw 15(2):1–11
35.
Zurück zum Zitat Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 57:289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 57:289–300
36.
Zurück zum Zitat Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. PLoS Med 4:e297CrossRefPubMedPubMedCentral Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. PLoS Med 4:e297CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Pankow JS, Duncan BB, Schmidt MI et al (2004) Fasting plasma free fatty acids and risk of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes Care 27:77–82CrossRefPubMed Pankow JS, Duncan BB, Schmidt MI et al (2004) Fasting plasma free fatty acids and risk of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes Care 27:77–82CrossRefPubMed
38.
Zurück zum Zitat Rebelos E, Seghieri M, Natali A et al (2015) Influence of endogenous NEFA on beta cell function in humans. Diabetologia 58:2344–2351CrossRefPubMed Rebelos E, Seghieri M, Natali A et al (2015) Influence of endogenous NEFA on beta cell function in humans. Diabetologia 58:2344–2351CrossRefPubMed
39.
Zurück zum Zitat Giacca A, Xiao C, Oprescu AI et al (2011) Lipid-induced pancreatic beta-cell dysfunction: Focus on in vivo studies. Am J Physiol Endocrinol Metab 300:E255–E262CrossRefPubMed Giacca A, Xiao C, Oprescu AI et al (2011) Lipid-induced pancreatic beta-cell dysfunction: Focus on in vivo studies. Am J Physiol Endocrinol Metab 300:E255–E262CrossRefPubMed
40.
Zurück zum Zitat Xiao C, Giacca A, Lewis GF (2009) The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and beta-cell dysfunction in overweight and obese nondiabetic men. Am J Physiol Endocrinol Metab 297:E1205–E1211CrossRefPubMed Xiao C, Giacca A, Lewis GF (2009) The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and beta-cell dysfunction in overweight and obese nondiabetic men. Am J Physiol Endocrinol Metab 297:E1205–E1211CrossRefPubMed
41.
Zurück zum Zitat Morita S, Shimajiri Y, Sakagashira S et al (2012) Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with type 2 diabetes: a long-term follow-up study. Diabet Med 29:980–985CrossRefPubMed Morita S, Shimajiri Y, Sakagashira S et al (2012) Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with type 2 diabetes: a long-term follow-up study. Diabet Med 29:980–985CrossRefPubMed
42.
Zurück zum Zitat Nielsen S, Karpe F (2012) Determinants of VLDL-triglycerides production. Curr Opin Lipidol 23:321–326CrossRefPubMed Nielsen S, Karpe F (2012) Determinants of VLDL-triglycerides production. Curr Opin Lipidol 23:321–326CrossRefPubMed
43.
Zurück zum Zitat Martins AR, Nachbar RT, Gorjao R et al (2012) Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: Importance of the mitochondrial function. Lipids Health Dis 11:30CrossRefPubMedPubMedCentral Martins AR, Nachbar RT, Gorjao R et al (2012) Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: Importance of the mitochondrial function. Lipids Health Dis 11:30CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Capurso C, Capurso A (2012) From excess adiposity to insulin resistance: The role of free fatty acids. Vasc Pharmacol 57:91–97CrossRef Capurso C, Capurso A (2012) From excess adiposity to insulin resistance: The role of free fatty acids. Vasc Pharmacol 57:91–97CrossRef
46.
Zurück zum Zitat Steffen BT, Steffen LM, Zhou X et al (2015) n-3 Fatty acids attenuate the risk of diabetes associated with elevated serum nonesterified fatty acids: The multi-ethnic study of atherosclerosis. Diabetes Care 38:575–580PubMedPubMedCentral Steffen BT, Steffen LM, Zhou X et al (2015) n-3 Fatty acids attenuate the risk of diabetes associated with elevated serum nonesterified fatty acids: The multi-ethnic study of atherosclerosis. Diabetes Care 38:575–580PubMedPubMedCentral
47.
Zurück zum Zitat Virtanen JK, Mursu J, Voutilainen S et al (2014) Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: The kuopio ischemic heart disease risk factor study. Diabetes Care 37:189–196CrossRefPubMed Virtanen JK, Mursu J, Voutilainen S et al (2014) Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: The kuopio ischemic heart disease risk factor study. Diabetes Care 37:189–196CrossRefPubMed
48.
Zurück zum Zitat Sarbolouki S, Javanbakht MH, Derakhshanian H et al (2013) Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: A double-blind randomised clinical trial. Singap Med J 54:387–390CrossRef Sarbolouki S, Javanbakht MH, Derakhshanian H et al (2013) Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: A double-blind randomised clinical trial. Singap Med J 54:387–390CrossRef
49.
Zurück zum Zitat Calder PC (2009) Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 91:791–795CrossRefPubMed Calder PC (2009) Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 91:791–795CrossRefPubMed
50.
Zurück zum Zitat Magkos F, Fabbrini E, Conte C et al (2012) Relationship between adipose tissue lipolytic activity and skeletal muscle insulin resistance in nondiabetic women. J Clin Endocrinol Metab 97:E1219–E1223CrossRefPubMedPubMedCentral Magkos F, Fabbrini E, Conte C et al (2012) Relationship between adipose tissue lipolytic activity and skeletal muscle insulin resistance in nondiabetic women. J Clin Endocrinol Metab 97:E1219–E1223CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Almandoz JP, Singh E, Howell LA et al (2013) Spillover of fatty acids during dietary fat storage in type 2 diabetes: relationship to body fat depots and effects of weight loss. Diabetes 62:1897–1903CrossRefPubMedPubMedCentral Almandoz JP, Singh E, Howell LA et al (2013) Spillover of fatty acids during dietary fat storage in type 2 diabetes: relationship to body fat depots and effects of weight loss. Diabetes 62:1897–1903CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Dai L, Gonçalves CMV, Lin Z et al (2015) Exploring metabolic syndrome serum free fatty acid profiles based on GC-SIM-MS combined with random forests and canonical correlation analysis. Talanta 135:108–114CrossRefPubMed Dai L, Gonçalves CMV, Lin Z et al (2015) Exploring metabolic syndrome serum free fatty acid profiles based on GC-SIM-MS combined with random forests and canonical correlation analysis. Talanta 135:108–114CrossRefPubMed
53.
Zurück zum Zitat Liu L, Li Y, Guan C et al (2010) Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J Chromatogr B Anal Technol Biomed Life Sci 878:2817–2825CrossRef Liu L, Li Y, Guan C et al (2010) Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J Chromatogr B Anal Technol Biomed Life Sci 878:2817–2825CrossRef
Metadaten
Titel
Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort
verfasst von
Luke W. Johnston
Stewart B. Harris
Ravi Retnakaran
Adria Giacca
Zhen Liu
Richard P. Bazinet
Anthony J. Hanley
Publikationsdatum
24.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 4/2018
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4534-6

Weitere Artikel der Ausgabe 4/2018

Diabetologia 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.